GlassScriptPhysician profile
Daniel S Feivor
NPI 1164040960
$1,595.88
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $650 · 2022: $825 · 2023: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $120.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $340.44 | 2021-2023 | Tirosint, Licart |
| Abbvie INC. | $282.37 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $180.35 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $179.29 | 2022 | |
| Horizon Therapeutics Plc | $93.60 | 2021-2022 | |
| Relievant Medsystems, INC. | $74.37 | 2022 | |
| Nevro Corp. | $72.48 | 2021 | |
| Grt US Holding, INC. | $39.82 | 2022 | |
| Upsher-Smith Laboratories LLC | $38.35 | 2022 | |
| Arbor Pharmaceuticals, INC. | $36.39 | 2021 | |
| Averitas Pharma INC. | $35.61 | 2023 | Qutenza |
| Stryker Corporation | $35.41 | 2022 | |
| Fidia Pharma USA INC. | $30.71 | 2022 | |
| Trice Medical, INC. | $27.40 | 2022 | |
| Depuy Synthes Sales INC. | $27.36 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $19.06 | 2021 | |
| Pfizer INC. | $19.00 | 2021 | |
| Genzyme Corporation | $17.93 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.71 | 2022 | |
| Vertos Medical, INC. | $16.88 | 2021 | |
| Currax Pharmaceuticals LLC | $11.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Feivor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.